TORONTO, July 28, 2025--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable ...
Safety Finding Based on Blinded MRI Brain Data at Week 40 ARIA is a Known Risk Factor for Anti-Amyloid Antibody Drugs MRI Data Presented at the 16th CTAD Conference in Boston, MA AUSTIN, Texas, Oct.
icometrix, a global leader in AI-driven software, announced that on November 7, 2024, the US Food and Drug Administration (FDA) granted the company clearance for icobrain aria, the first and only AI ...
AUSTIN, Texas, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, today announced a potentially significant safety finding based on ...
Interim results from the CARE PMR study support the use of ultra-low-field MRI as a triage tool for monitoring patients on amyloid-targeting therapies. Researchers from the Benzinger Lab at Washington ...
Interim results from the CARE PMR study support the use of ultra-low-field MRI as a triage tool for monitoring patients on amyloid-targeting therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results